SCHEMBL5814788

SCHEMBL5814788

O=C(N/N=C/Cc1ccccc1O)c1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
GAA P10253 2/20 0.56
RAB9A P51151 5/20 0.50
NPC1 O15118 5/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
MAPT P10636 2/20 0.49
KDM1A O60341 2/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812806 1.00 POLB (0.56) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL5815125 0.88 ALDH1A1 (0.50) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5809769 0.85 NPC1 (0.61) RAB9ANPC1SMN1; SMN2MAPTKMT2A
SCHEMBL5809674 0.77 NPC1 (0.50) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL5809953 0.77 NPC1 (0.50) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL1913833 0.77 KDM4E (0.52) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL15882846 0.76 MEN1 (0.55) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL12746361 0.75 KDM1A (0.81) POLBGAARAB9ANPC1SMN1; SMN2
SCHEMBL5809466 0.75 ALDH1A1 (0.54) GAARAB9ANPC1SMN1; SMN2MAPT
SCHEMBL5814381 0.75 ALDH1A1 (0.54) GAARAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed